Sunday, December 21, 2025 | 02:22 PM ISTहिंदी में पढें
Business Standard
Notification Icon
userprofile IconSearch

Aventis Pharma launches SoloStar in India

Image

BS Reporter Ahmedabad

"The insulin market in India is about Rs 410 crore and we have captured a market of about 7% with Lantus. The launch of SoloStar will boost our market share by another 1-2%," said Susheel Umesh, senior director, Cardio-Metabolism Business Unit who was in Ahmedabad for the launch. The Chicago Athenaeum Museum of Architecture and Design awarded the 2007 Good Design award to SoloStar.

 

Lantus has a global market of 2 billion Euros. SoloStar reduces the injection force by 30% or more in comparison to other leading disposable pens, he added.

According to diabetologist Sanjeev Phatak after Tamil Nadu, Gujarat has highest prevalence of diabetes. "There would be 30-40 lakh diabetes patients in Gujarat of which about 4-5 lakh would be in Ahmedabad," Phatak said.

Don't miss the most important news and views of the day. Get them on our Telegram channel

First Published: May 13 2008 | 6:13 PM IST

Explore News